QIAGEN Reporting
Effective
The sample and assay technology provider has developed a comprehensive portfolio of molecular-based SARS-CoV-2 testing solutions over the past year. In doing so, QIAGEN is making an important contribution on the global road back to normality. A chronicle in the "INSIGHTS" magazine accompanying the annual report traces how the company has mastered this challenge.
Starting with the smallest parts, QIAGEN makes big things happen.
In the clearly structured, lively publication, readers also experience how QIAGEN's international team is helping to eliminate tuberculosis or supporting the rescue of rare corals – and remains successful in the most unusual year in the company's history.
Questions about the project?
Rohwa Jung
